Lake Forest, Ca., USA - Cryoport, Inc., a provider of cryogenic logistics solutions for life sciences markets, announced the appointment of Robert Hariri to its board of directors.
Article continues below
Dr. Hariri is the Chairman, Founder and Chief Scientific Officer of Celgene Cellular Therapeutics, one of the world’s largest human cellular therapeutics companies and wholly owned subsidiary of Celgene Corporation. He has pioneered the use of stem cells and biomaterials to treat a range of life threatening diseases and has made transformative contributions in the field of tissue engineering.
Dr. Hariri is a visionary scientist, surgeon, aviator and entrepreneur. He has over 100 issued and pending patents; authored over 100 published chapters, articles and abstracts; and is most recognized for his discovery of pluripotent stem cells from the placenta and as a member of the team which discovered the physiological activities of TNF (tumor necrosis factor).
Along with J. Craig Venter, PhD, Dr. Hariri, is Co-Founder & President of Human Longevity Cellular Therapeutics, Inc. located in San Diego, CA, a genomics and cellular technology company.
He is Founder and Chairman of Myos Corporation located in Cedar Knolls, NJ (NASDAQ: MYOS ), an emerging bio-therapeutics and bio-nutrition company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and chronic and acute muscle diseases.
Dr. Hariri also serves on numerous Boards of Directors, including Myos Corporation, Bionik Laboratories and Provista Diagnostics. He is a member of the scientific advisory board for the Archon X PRIZE for Genomics, which is awarded by the X PRIZE Foundation.
He is also a member of the Board of Trustees of the J. Craig Venter Institute, a Trustee of the Liberty Science Center and has been appointed Commissioner of the New Jersey Commission on Cancer Research.
Dr. Hariri was recipient of the Thomas Alva Edison Award in 2007 and 2011, The Fred J. Epstein Lifetime Achievement Award and has received numerous other honors for his many contributions to biomedicine and aviation.
He is an Adjunct Associate Professor of Pathology at the Mount Sinai School of Medicine and served as a member of the Board of Visitors of his alma mater, Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons. ■